ACE2 interaction networks in COVID-19: a physiological framework for prediction of outcome in patients with cardiovascular risk factors

  1. Zofia Wicik
  2. Ceren Eyileten
  3. Daniel Jakubik
  4. Sérgio N Simões
  5. David C Martins
  6. Rodrigo Pavão
  7. Jolanta M. Siller-Matula
  8. Marek Postula

Reviewed by

Read the full article

Listed in

Log in to save this article

Abstract

(1)

Background

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (coronavirus disease 2019; COVID-19) is associated with adverse outcomes in patients with cardiovascular disease (CVD). The aim of the study was to characterize the interaction between SARS-CoV-2 and Angiotensin-Converting Enzyme 2 (ACE2) functional networks with a focus on CVD.;

(2)

Methods

Using the network medicine approach and publicly available datasets, we investigated ACE2 tissue expression and described ACE2 interaction networks which could be affected by SARS-CoV-2 infection in the heart, lungs and nervous system. We compared them with changes in ACE-2 networks following SARS-CoV-2 infection by analyzing public data of stem cell-derived cardiomyocytes (hiPSC-CMs). This analysis was performed using the NERI algorithm, which integrates protein-protein interaction with co-expression networks. We also performed miRNA-target predictions to identify which ones regulate ACE2-related networks and could play a role in the COVID19 outcome. Finally, we performed enrichment analysis for identifying the main COVID-19 risk groups.

(3)

Results

We found similar ACE2 expression confidence levels in respiratory and cardiovascular systems, supporting that heart tissue is a potential target of SARS-CoV-2. Analysis of ACE2 interaction networks in infected hiPSC-CMs identified multiple hub genes with corrupted signalling which can be responsible for cardiovascular symptoms. The most affected genes were EGFR, FN1, TP53, HSP90AA1, and APP, while the most affected interactions were associated with MAST2 and CALM1. Enrichment analysis revealed multiple diseases associated with the interaction networks of ACE2, especially cancerous diseases, obesity, hypertensive disease, Alzheimer’s disease, non-insulin-dependent diabetes mellitus, and congestive heart failure. Among affected ACE2-network components connected with SARS-Cov-2 interactome, we identified AGT, CAT, DPP4, CCL2, TFRC and CAV1, associated with cardiovascular risk factors. We described for the first time miRNAs which were common regulators of ACE2 networks and virus-related proteins in all analyzed datasets. The top miRNAs were miR-27a-3p, miR-26b-5p, miR-10b-5p, miR-302c-5p, hsa-miR-587, hsa-miR-1305, hsa-miR-200b-3p, hsa-miR-124-3p, and hsa-miR-16-5p.;

(4)

Conclusion

Our study provides a complete mechanistic framework for investigating the ACE2 network which was validated by expression data. This framework predicted risk groups, including the established ones, thus providing reliable novel information regarding the complexity of signalling pathways affected by SARS-CoV-2. It also identified miR which could be used in personalized diagnosis in COVID-19.

Article activity feed

  1. Version published to 10.1101/2020.05.13.094714v3 on bioRxiv
  2. ScreenIT

    SciScore for 10.1101/2020.05.13.094714: (What is this?)

    Please note, not all rigor criteria are appropriate for all manuscripts.

    Table 1: Rigor

    NIH rigor criteria are not applicable to paper type.

    Table 2: Resources

    Software and Algorithms
    SentencesResources
    Data collection: ACE2-associated genes used for constructing interaction networks were extracted from KEGG database (23 genes from renin-angiotensin system-RAS pathway) [20]; stringApp (top 40 ACE2 interactors) [21], Archs4 database https://amp.pharm.mssm.edu/archs4 (top 20 genes with correlated expression), Genecards database https://www.genecards.org (5 interactors and 4 sister terms), literature search [22–24].
    Archs4
    suggested: (ARCHS4, RRID:SCR_015683)
    Genecards
    suggested: (GeneCards, RRID:SCR_002773)
    Tissues 2.0 database integrates:
    Tissues
    suggested: None
    Enrichment analysis of the diseases and networks was done with the EnrichR database [32], using Fisher’s exact with Benjamini and Hochberg correction, while the reference was precomputed background for each term in each gene set library.
    EnrichR
    suggested: (Enrichr, RRID:SCR_001575)
    Signalling pathways were analyzed using BioPlanet2019 and Human KEGG 2019 datasets.
    BioPlanet2019
    suggested: None
    KEGG
    suggested: (KEGG, RRID:SCR_012773)
    Interaction networks between ACE2-related genes and miRNAs were constructed in R and exported to Cytoscape 3.7.2.
    Cytoscape
    suggested: (Cytoscape, RRID:SCR_003032)

    Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).

    Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.

    Results from TrialIdentifier: No clinical trial numbers were referenced.

    Results from Barzooka: We did not find any issues relating to the usage of bar graphs.

    Results from JetFighter: We did not find any issues relating to colormaps.

    Results from rtransparent:
    • Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
    • Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
    • No protocol registration statement was detected.

    About SciScore

    SciScore is an automated tool that is designed to assist expert reviewers by finding and presenting formulaic information scattered throughout a paper in a standard, easy to digest format. SciScore checks for the presence and correctness of RRIDs (research resource identifiers), and for rigor criteria such as sex and investigator blinding. For details on the theoretical underpinning of rigor criteria and the tools shown here, including references cited, please follow this link.

  3. Version published to 10.1101/2020.05.13.094714v2 on bioRxiv
  4. Version published to 10.1101/2020.05.13.094714v1 on bioRxiv